The 2025 MIT Japan Conference will explore future research trends at MIT, highlighting breakthroughs in key areas such as Soft Materials and Mechanics, Biomedical Innovation, and the impact of Generative AI (GAI) on the Work of the Future. Additional sessions will focus on Quantum and Silicon Photonics, Nanotechnology in materials and additive manufacturing, and the latest Machine Learning and AI tools for chemical discovery. Advances in semiconductor technology, hydrogen innovation, and electrochemistry, as well as thermofluidic interfaces, will also be featured.
Please visit the MIT ILP site for the full agenda.
How can P&G enable consumers to do radically more with radically less water and energy use? How can we make invisible use of water & energy visible, right at the point of use? How might we particularly address the triangle of tension that exists between improving sanitization, reducing water & energy, whilst keeping the feeling of abundance of using water?. From incremental evolution to product innovation, easy-retrofit water-infrastructure changes (taps, faucets, showerheads, etc.) and water appliances that aim at both reducing (hot) water and re-using/purifying/enriching (hot) water, we want to partner!
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
Trond Undheim, Program Director, MIT Startup Exchange
Procter & Gamble is looking for new approaches and technologies that can help them to address key business challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.